{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:14Z","timestamp":1787032814333,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.7759\/cureus.100565","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T15:41:04Z","timestamp":1767282064000},"source":"Crossref","is-referenced-by-count":1,"title":["Granulomas in the Heart: Pathophysiology, Diagnosis, Management, and Outcomes in Cardiac Sarcoidosis"],"prefix":"10.7759","author":[{"given":"Mayar B","family":"Alnasralla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Subbaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie DH","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016, 68:411-21. 10.1016\/j.jacc.2016.03.605","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri V","year":"2011","unstructured":"Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011, 7:546-54. 10.5114\/aoms.2011.24118","journal-title":"Arch Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi MC","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007, 357:2153-65. 10.1056\/NEJMra071714","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara M","year":"2006","unstructured":"Miyara M, Amoura Z, Parizot C, et al.. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med. 2006, 203:359-70. 10.1084\/jem.20050648","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2000.560107.x","article-title":"HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis","volume":"56","author":"Naruse TK","year":"2000","unstructured":"Naruse TK, Matsuzawa Y, Ota M, et al.. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens. 2000, 56:52-7. 10.1034\/j.1399-0039.2000.560107.x","journal-title":"Tissue Antigens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010251","article-title":"Histology of cardiac sarcoidosis with novel considerations arranged upon a pathologic basis","volume":"11","author":"Kato S","year":"2022","unstructured":"Kato S, Sakai Y, Okabe A, et al.. Histology of cardiac sarcoidosis with novel considerations arranged upon a pathologic basis. J Clin Med. 2022, 11:251. 10.3390\/jcm11010251","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen J","year":"2023","unstructured":"Lehtonen J, Uusitalo V, P\u00f6yh\u00f6nen P, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023, 44:1495-510. 10.1093\/eurheartj\/ehad067","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie DH","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al.. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014, 11:1305-23. 10.1016\/j.hrthm.2014.03.043","journal-title":"Heart Rhythm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1104947","article-title":"Management of the arrhythmic manifestations of cardiac sarcoidosis","volume":"10","author":"Cherrett C","year":"2023","unstructured":"Cherrett C, Lee W, Bart N, Subbiah R. Management of the arrhythmic manifestations of cardiac sarcoidosis. Front Cardiovasc Med. 2023, 10:1104947. 10.3389\/fcvm.2023.1104947","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034687","article-title":"Ventricular arrhythmias in cardiac sarcoidosis","volume":"138","author":"Okada DR","year":"2018","unstructured":"Okada DR, Smith J, Derakhshan A, et al.. Ventricular arrhythmias in cardiac sarcoidosis. Circulation. 2018, 138:1253-64. 10.1161\/CIRCULATIONAHA.118.034687","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1156474","article-title":"Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies","volume":"10","author":"Shah HH","year":"2023","unstructured":"Shah HH, Zehra SA, Shahrukh A, et al.. Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies. Front Cardiovasc Med. 2023, 10:1156474. 10.3389\/fcvm.2023.1156474","journal-title":"Front Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng RK","year":"2024","unstructured":"Cheng RK, Kittleson MM, Beavers CJ, et al.. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation. 2024, 149:e1197-216. 10.1161\/CIR.0000000000001240","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.10.150","article-title":"Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria","volume":"345","author":"Takaya Y","year":"2021","unstructured":"Takaya Y, Nakamura K, Nishii N, Ito H. Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria. Int J Cardiol. 2021, 345:49-53. 10.1016\/j.ijcard.2021.10.150","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/life13081653","article-title":"The role of echocardiography in the contemporary diagnosis and prognosis of cardiac sarcoidosis: a comprehensive review","volume":"13","author":"Okafor J","year":"2023","unstructured":"Okafor J, Khattar R, Sharma R, Kouranos V. The role of echocardiography in the contemporary diagnosis and prognosis of cardiac sarcoidosis: a comprehensive review. Life (Basel). 2023, 13:1653. 10.3390\/life13081653","journal-title":"Life (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger R","year":"2020","unstructured":"Kraaijvanger R, Janssen Bon\u00e1s M, Vorselaars AD, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020, 11:1443. 10.3389\/fimmu.2020.01443","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.785279","article-title":"Current state and future directions of multimodality imaging in cardiac sarcoidosis","volume":"8","author":"Wand AL","year":"2022","unstructured":"Wand AL, Chrispin J, Saad E, Mukherjee M, Hays AG, Gilotra NA. Current state and future directions of multimodality imaging in cardiac sarcoidosis. Front Cardiovasc Med. 2022, 8:785279. 10.3389\/fcvm.2021.785279","journal-title":"Front Cardiovasc Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson A","year":"2023","unstructured":"Stevenson A, Bray JJ, Tregidgo L, et al.. Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2023, 16:345-57. 10.1016\/j.jcmg.2022.10.018","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis","volume":"8","author":"Tonegawa-Kuji R","year":"2021","unstructured":"Tonegawa-Kuji R, Oyama-Manabe N, Aoki R, Nagayoshi S, Pawhay CM, Kusano K, Nakajima T. T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis. Open Heart. 2021, 8:e001728. 10.1136\/openhrt-2021-001728","journal-title":"Open Heart"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2020190140","article-title":"Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis","volume":"2","author":"Coulden RA","year":"2020","unstructured":"Coulden RA, Sonnex EP, Abele JT, Crean AM. Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis. Radiol Cardiothorac Imaging. 2020, 2:e190140. 10.1148\/ryct.2020190140","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung E","year":"2021","unstructured":"Cheung E, Ahmad S, Aitken M, et al.. Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging. 2021, 5:24. 10.1186\/s41824-021-00119-w","journal-title":"Eur J Hybrid Imaging"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245808","article-title":"Advances in diagnostic imaging for cardiac sarcoidosis","volume":"10","author":"Manabe O","year":"2021","unstructured":"Manabe O, Oyama-Manabe N, Aikawa T, Tsuneta S, Tamaki N. Advances in diagnostic imaging for cardiac sarcoidosis. J Clin Med. 2021, 10:5808. 10.3390\/jcm10245808","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046900","article-title":"Diagnostic yield of electroanatomic voltage mapping in guiding endomyocardial biopsies","volume":"142","author":"Casella M","year":"2020","unstructured":"Casella M, Dello Russo A, Bergonti M, et al.. Diagnostic yield of electroanatomic voltage mapping in guiding endomyocardial biopsies. Circulation. 2020, 142:1249-60. 10.1161\/CIRCULATIONAHA.120.046900","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2016.06.002","article-title":"Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography","volume":"14","author":"Kawakatsu N","year":"2016","unstructured":"Kawakatsu N, Suzuki A, Serizawa N, et al.. Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography. J Cardiol Cases. 2016, 14:107-10. 10.1016\/j.jccase.2016.06.002","journal-title":"J Cardiol Cases"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706263362603","article-title":"Idiopathic giant-cell myocarditis\u2014natural history and treatment","volume":"336","author":"Cooper LT Jr","year":"1997","unstructured":"Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis\u2014natural history and treatment. N Engl J Med. 1997, 336:1860-6. 10.1056\/NEJM199706263362603","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki F","year":"2017","unstructured":"Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017, 3:42-5. 10.17996\/anc.17-00042","journal-title":"Ann Nucl Cardiol"},{"key":"ref26","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson MA","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, et al.. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014, 31:19-27.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2021.16","article-title":"Cardiac sarcoidosis: when and how to treat inflammation","volume":"7","author":"Giblin GT","year":"2021","unstructured":"Giblin GT, Murphy L, Stewart GC, et al.. Cardiac sarcoidosis: when and how to treat inflammation. Card Fail Rev. 2021, 7:e17. 10.15420\/cfr.2021.16","journal-title":"Card Fail Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae692","article-title":"Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis","volume":"64","author":"Brooks L","year":"2025","unstructured":"Brooks L, Kivlin W, Mohananey D, Sabchyshyn V, Putman M. Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis. Rheumatology (Oxford). 2025, 64:3303-8. 10.1093\/rheumatology\/keae692","journal-title":"Rheumatology (Oxford)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis","volume":"124","author":"Harper LJ","year":"2019","unstructured":"Harper LJ, McCarthy M, Ribeiro Neto ML, et al.. Infliximab for refractory cardiac sarcoidosis. Am J Cardiol. 2019, 124:1630-5. 10.1016\/j.amjcard.2019.07.067","journal-title":"Am J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker MC","year":"2020","unstructured":"Baker MC, Sheth K, Witteles R, Genovese MC, Shoor S, Simard JF. TNF-alpha inhibition for the treatment of cardiac sarcoidosis. Semin Arthritis Rheum. 2020, 50:546-52. 10.1016\/j.semarthrit.2019.11.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou N","year":"2018","unstructured":"Papageorgiou N, Provid\u00eancia R, Bronis K, Dechering DG, Srinivasan N, Eckardt L, Lambiase PD. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace. 2018, 20:682-91. 10.1093\/europace\/eux077","journal-title":"Europace"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2024.15115","article-title":"Device therapy in cardiac sarcoidosis: current review, challenges, and future prospects","volume":"15","author":"ElRefai M","year":"2024","unstructured":"ElRefai M, Menexi C, Roberts PR. Device therapy in cardiac sarcoidosis: current review, challenges, and future prospects. J Innov Card Rhythm Manag. 2024, 15:6088-94. 10.19102\/icrm.2024.15115","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1394075","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"11","author":"Aftab A","year":"2024","unstructured":"Aftab A, Szeto S, Aftab Z, Bokhari S. Cardiac sarcoidosis: diagnosis and management. Front Cardiovasc Med. 2024, 11:1394075. 10.3389\/fcvm.2024.1394075","journal-title":"Front Cardiovasc Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub P","year":"2020","unstructured":"Cacoub P, Chapelon-Abric C, Resche-Rigon M, Saadoun D, Desbois AC, Biard L. Cardiac sarcoidosis: a long term follow up study. PLoS One. 2020, 15:e0238391. 10.1371\/journal.pone.0238391","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028342","article-title":"Long-term outcomes of cardiac sarcoid: prognostic implications of isolated cardiac involvement and impact of diagnostic delays","volume":"12","author":"Sink J","year":"2023","unstructured":"Sink J, Joyce C, Liebo MJ, Wilber DJ. Long-term outcomes of cardiac sarcoid: prognostic implications of isolated cardiac involvement and impact of diagnostic delays. J Am Heart Assoc. 2023, 12:e028342. 10.1161\/JAHA.122.028342","journal-title":"J Am Heart Assoc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro MG","year":"2018","unstructured":"Crespo-Leiro MG, Metra M, Lund LH, et al.. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018, 20:1505-35. 10.1002\/ejhf.1236","journal-title":"Eur J Heart Fail"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2025.103068","article-title":"Assessing prognostic outcomes in cardiac sarcoidosis with advanced heart failure: how do current guidelines fare?","volume":"50","author":"Singh M","year":"2025","unstructured":"Singh M, Ahmed R, Umeojiako WI, et al.. Assessing prognostic outcomes in cardiac sarcoidosis with advanced heart failure: how do current guidelines fare?. Curr Probl Cardiol. 2025, 50:103068. 10.1016\/j.cpcardiol.2025.103068","journal-title":"Curr Probl Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421660-granulomas-in-the-heart-pathophysiology-diagnosis-management-and-outcomes-in-cardiac-sarcoidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T15:41:05Z","timestamp":1767282065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421660-granulomas-in-the-heart-pathophysiology-diagnosis-management-and-outcomes-in-cardiac-sarcoidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.100565","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}